Skip to main content

Table 2 Dose and response

From: Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation

Total dose

CR

PR

Total

Pvalue

30 to < 40 Gy

1 (25.0%)

3 (75.0%)

4

0.670

≥40 to 46 Gy

6 (28.6%)

15 (71.4%)

21

 

≥50 to 60 Gy

2 (50.0%)

2 (50.0%)

4

 

Total

9

20

29

 
  1. Pearson's chi-square is used to assess P value
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us